D
Cardiff Oncology, Inc. CRDF
$4.00 $0.051.27%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue 40.16% 49.78% 61.41% 54.43% 26.42%
Total Other Revenue -- -- -- -- --
Total Revenue 40.16% 49.78% 61.41% 54.43% 26.42%
Cost of Revenue 12.16% 10.68% 12.75% 9.89% 21.21%
Gross Profit -11.74% -10.10% -12.06% -9.27% -21.14%
SG&A Expenses -4.30% -8.96% -11.27% 6.22% -1.05%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 7.48% 4.83% 5.20% 8.79% 13.93%
Operating Income -7.13% -4.36% -4.65% -8.35% -13.81%
Income Before Tax -9.63% -5.34% -3.07% -3.33% -7.07%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -9.63% -5.34% -3.07% -3.33% -7.07%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -9.63% -5.34% -3.07% -3.33% -7.07%
EBIT -7.13% -4.36% -4.65% -8.35% -13.81%
EBITDA -7.18% -4.33% -4.55% -8.13% -13.48%
EPS Basic -3.20% -3.82% -2.20% -1.68% -4.38%
Normalized Basic EPS -3.19% -3.80% -2.18% -1.68% -4.39%
EPS Diluted -3.20% -3.82% -2.20% -1.68% -4.38%
Normalized Diluted EPS -3.19% -3.80% -2.18% -1.68% -4.39%
Average Basic Shares Outstanding 6.65% 1.39% 0.93% 1.63% 2.47%
Average Diluted Shares Outstanding 6.65% 1.39% 0.93% 1.63% 2.47%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings